Novo Nordisk A/s logo

Novo Nordisk A/s (NVO)

$117

Novo Nordisk A/s (NVO) Share Price Forecast
Currently 32 wall-street analysts regularly analyze the financials of Novo Nordisk A/s on a frequent basis to provide recommendations along with target share price. 32 analysts offering 12-month price forecasts for Novo Nordisk A/s (NVO) have a share price target of $142.95. This median of share price forecast represents a 22.18% upside from the latest price of $117 as on 11.10.24.

Novo Nordisk A/s (NVO) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Novo Nordisk A/s (NVO) share price will touch around $142.95 in next 12-months.
Novo Nordisk A/s (NVO) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Novo Nordisk A/s's share price and its median forecast price. As on 11.10.24, the difference is -17.45%

Novo Nordisk A/s (NVO): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Novo Nordisk A/s (NVO) Share Price : Analyst Recommendation
Based on 32 analysts tracking and researching Novo Nordisk A/s (NVO) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
13
14
14
Outperform
5
6
6
Hold
10
10
10
Underperform
2
1
2
Sell
1
0
0
Novo Nordisk A/s (NVO) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Novo Nordisk A/s (NVO) is $142.95, offered by 32 analysts offering 12-month price forecasts.

Novo Nordisk A/s (NVO) has a maximum of 0.22 upside potential, based on 32 analysts offering 12-month price forecasts.

Based on 32 analysts tracking and researching Novo Nordisk A/s (NVO), 62.5% have a buy recommendation. Remaining 37.5% have either sell or hold recommendations.

The latest share price of Novo Nordisk A/s (NVO) is $117 as of 11/10/2024.

20 of total 32 analysts offering stock ratings for Novo Nordisk A/s NVO have recommended buy rating.